Cytoo People in the News: Marc Le Bozec, Charles Lee, Ruby Gadelrab Premium French cell chip maker Cytoo has named Marc Le Bozec as its new CEO. People in the News: Olivier Pasquier Premium French cell chip company Cytoo has named Olivier Pasquier as its chief commercial officer. Pasquier was Qiagen's senior marketing manager in Europe before joining Cytoo. Cytoo to Introduce 2D+ Cell Culture Platform, Custom Cell Screening Assay Services Premium Cytoo will later this month introduce its 2D+ cell culture platform and accompanying custom services, according to a company spokesperson. New Products: CTGT's HDT Array Tests, Cytoo's CytooPlates Motility Premium Connective Tissue Gene Tests has released five new tests for mutations, deletions, or duplications in genes related to connective tissue disorders. Cytoo to Complement Chip Offering with Plates for Studying Cell Migration Premium This story was originally posted on Oct. 18 Cytoo, a French life sciences tools provider, will soon launch a microplate version of its CytooChips Motility chip for studying cell migration, according to a company spokeperson. Dec 13, 2011 Cytoo to Lead $5.3M EU Project to Adapt Cell Chips for RNAi Screening Premium Dec 13, 2011 EU Awards $5.3M to Consortium Developing RNAi Screening Methods Nov 29, 2011 Cytoo to Spend $10M in New Funding on R&D, Marketing Activities Premium Nov 25, 2011 Cytoo Raises $10M in Series C Round Sep 26, 2011 Cytoo, Cellectis Bioresearch, CEA Receive $10.2M to Develop Cell-based Assays Jun 30, 2010 Cytoo, Buoyed by Nature Methods Study, to Debut New Cell-Screening Plates, Chips Premium Dec 1, 2009 French Cell Chip Maker Cytoo Raises $4.7M, Opens US Shop Premium Sep 28, 2009 France's Cytoo Raises $4.7M to Grow High-Content Cell Analysis Business Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.